MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • MDS Virtual Congress 2021

    The fear of progression of Parkinson’s Disease

    S. Mayer, E. Tekampe, A. Frank, T. Feige, H. Reichmann, B. Falkenburger (Dresden, Germany)

    Objective: Determine fear of progression (FoP) and its influencing factors in Parkinson's disease (PD) patients to alleviate the psychosocial distress it induces. Background: PD patients…
  • MDS Virtual Congress 2021

    Prevalence of neurogenic orthostatic hypotension in the idiopathic Parkinson Progression Marker Initiative cohort.

    P. Beach, J. Mckay (Atlanta, USA)

    Objective: To assess prevalence of neurogenic and peripheral orthostatic hypotension (nOH/pOH) in the PPMI (https://www.ppmi-info.org) idiopathic Parkinson disease (PD) cohort and to examine whether nOH,…
  • MDS Virtual Congress 2021

    The Neuropsychiatric Inventory:Assessment Of Neuropsychiatric Symptoms In Parkinson’s Disease

    GG. Uygun, GA. Yuksel, S. Kose (Istanbul, Turkey)

    Objective: We investigated the correlation of Neuropsychiatric Inventory(NPI) test score with progression of PD. Background: PD has characteristic motor symptoms and non-motor symptoms including psychiatric…
  • MDS Virtual Congress 2021

    Nurse-led rapid access mental health clinic: a new care pathway in Parkinson’s disease

    S. Lidstone, K. Marcelle (Toronto, Canada)

    Objective: To provide rapid evaluation and non-pharmacological treatment of mental health symptoms in Parkinson's disease (PD) patients and their caregivers. Background: Mental health problems are…
  • MDS Virtual Congress 2021

    Anxiety and depression in patients with Parkinson’s disease selected for magnetic resonance-guided focused ultrasound thalamotomy.

    O. Kachemaeva, R. Galimova, D. Krekotin, Y. Sidorova, I. Buzaev, A. Saveliev, N. Mukhamadeeva, G. Akhmadeeva (Ufa, Russian Federation)

    Objective: To assess the severity of anxiety and depression in patients selected for treatment with the magnetic resonance-guided focused ultrasound thalamotomy (MRgFUS TT) before the…
  • MDS Virtual Congress 2021

    Does cognition, depression and quality of life influence the balance of elderly with Parkinson’s disease ?.

    L. Pereira, P. Broto, M. Terra, N. Barboza, H. Oliveira Araújo, M. Bueno, S. Smaili (Londrina, Brazil)

    Objective: To verify whether there is a correlation between cognition, depression and quality of life with balance in the elderly with Parkinson's disease. Background: Regarding…
  • MDS Virtual Congress 2021

    DNMSQuest: a simple tool for identifying mood disorders in cervical dystonia?

    S. Rafee, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

    Objective: To compare DNMSQuest scores with validated measures of mood disorder in cervical dystonia patients attending a hospital botulinum toxin clinic. We wished to determine…
  • MDS Virtual Congress 2021

    Implementing Systematic Screening and a Treatment Algorithm for Depression in Parkinson’s Disease

    C. Marras, A. Naito, J. Beck, R. de Leon, A. Allen, E. Nelson, D. Weintraub, S. Luo, S. Mantri, M. Neault (Toronto, Canada)

    Objective: Assess the feasibility and impact of systematic depression screening and management in movement disorders centers. Background: Depression is common in Parkinson’s disease (PD) and…
  • MDS Virtual Congress 2021

    Impact of Restless Leg Syndrome (RLS) Severity on Cognitive Function and Depression

    K. Mangipudi, C. Adler, N. Zhang, H. Shill, S. Mehta, C. Belden, A. Atri, E. Driver-Dunckley (Scottsdale, USA)

    Objective: To determine whether cognitive dysfunction and depression are more prevalent in RLS subjects compared to controls, and if RLS severity impacts these variables. Background:…
  • MDS Virtual Congress 2021

    Depression in Patients with Parkinson’s disease among Tomsk population

    M. Nikitina, N. Alifirova, K. Nurzhanova, N. Zhukova (Tomsk, Russian Federation)

    Objective: To identify clinical predictors of depression in Tomsk PwPD. Background: Depression is often an under-recognized feature of Parkinson's disease (PD). It is important to…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley